Evidence map›Paper›PMID 35335074›Full record

ArticleVaccines2022

The Influence of Time of Day of Vaccination with BNT162b2 on the Adverse Drug Reactions and Efficacy of Humoral Response against SARS-CoV-2 in an Observational Study of Young Adults.

Paweł Matryba, Karol Gawalski, Iga Ciesielska, Andrea Horvath, Zbigniew Bartoszewicz, Jacek Sienko, Urszula Ambroziak, Karolina Malesa-Tarasiuk, Anna Staniszewska, Jakub Golab and 1 more

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Circadian immunity from bench to bedside: a practical guide.The Journal of clinical investigation · 2024
    Review
  6. Review
  7. Observational
  8. Observational
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Paweł MatrybaDepartment of Immunology, Medical University of Warsaw, 02-097 Warsaw, Poland.
Karol GawalskiDepartment of Immunology, Medical University of Warsaw, 02-097 Warsaw, Poland.
Iga CiesielskaDepartment of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, 02-097 Warsaw, Poland.
Andrea HorvathDepartment of Pediatrics, Medical University of Warsaw, 02-097 Warsaw, Poland.ORCID 0000-0001-9940-0001
Zbigniew BartoszewiczDepartment of Internal Medicine and Endocrinology, Medical University of Warsaw, 02-097 Warsaw, Poland.
Jacek Sienko2nd Department of Obstetrics and Gynecology, Medical University of Warsaw, 02-097 Warsaw, Poland.ORCID 0000-0002-6277-5237
Urszula AmbroziakDepartment of Internal Medicine and Endocrinology, Medical University of Warsaw, 02-097 Warsaw, Poland.
Karolina Malesa-TarasiukDepartment of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, 02-097 Warsaw, Poland.
Anna StaniszewskaDepartment of Experimental and Clinical Pharmacology, Medical University of Warsaw, 02-097 Warsaw, Poland.ORCID 0000-0001-9851-367X
Jakub GolabDepartment of Immunology, Medical University of Warsaw, 02-097 Warsaw, Poland.
Rafał KrenkeDepartment of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, 02-097 Warsaw, Poland.
Medical University of Warsaw · PL

Funding

Ministerstwo Edukacji i Nauki 013/RID/2018/19
6 · The paper itself

Abstract

An increasing body of evidence from both academic and clinical studies shows that time-of-day exposure to antigens might significantly alter and modulate the development of adaptive immune responses. Considering the immense impact of the COVID-19 pandemic on global health and the diminished efficacy of vaccination in selected populations, such as older and immunocompromised patients, it is critical to search for the most optimal conditions for mounting immune responses against SARS-CoV-2. Hence, we conducted an observational study on 435 healthy young adults vaccinated with two doses of BNT162b2 (Pfizer-BioNTech) vaccine to determine whether time-of-day of vaccination influences either the magnitude of humoral response or number of adverse drug reactions (ADR) being reported. We found no significant differences between morning and afternoon vaccination in terms of both titers of anti-Spike antibodies and frequency of ADR in the studied population. In addition, our analysis of data on the occurrence of ADR in 1324 subjects demonstrated that the second administration of vaccine in those with previous SARS-CoV-2 infection was associated with lower incidence of ADR. In aggregate, vaccination against COVID-19 with two doses of BNT162b2 mRNA vaccine is presumed to generate an equally efficient anti-Spike humoral response.

Indexed as

adverse drug reactionsBNT162b2circadian rhythmCOVID-19humoral responseSARS-CoV-2time of dayvaccinationvaccine efficacyyoung adults

Identifiers

PMID35335074
PMCPMC8954058
OpenAlexW4221001439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.